What The Article Says: This devastating pandemic has affected nearly every aspect of daily life. While nations struggle to manage the initial waves of the death and disruption associated with the pandemic, accumulating evidence indicates another “second wave” is building: rising rates of mental health and substance use disorders.
Authors: Charles R. Marmar, M.D., of the NYU Langone Medical Center in New York, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
Editor’s Note: The article includes conflicts of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Media advisory: The full article is attached to this news release.
Embed this link to provide your readers free access to the full-text article This link will
DEPRESSION and anxiety disorders are psychosomatic conditions, i.e., a combination of psychological and physical factors. While the physical (or somatic) component of the condition is treated with anti-depressants, the psychologcal component is treated through psychotherapy.
Psychotherapy involves talking to a mental health professional such as a psychiatrist, psychologist, social worker or a counselor who first identify the reason for an anxiety disorder and how to alleviate the impact of the reason on the patient’s psyche. The particular type of psychotherapy that has been found very useful in treating anxiety disorders is: Cognitive-Behavioral Therapy (CBT). As its name suggests, CBT comrpises two elements: the cognitive element, and the behavioral element.
Cognitive element: The cognitive element of CBT helps people amend the thought structure that generates the fears and anxieties that have caused the anxiety disorder.
Behavioral element: The behavioral element of CBT encourages people to change the nature of their reaction … Read More
In this article we will examine why clinicians diagnose serious mental illnesses and why misdiagnosis is a common factor in the process. Looking at the definitions of schizophrenia and labelling as an incidence of laziness, misunderstanding, poor training and guidance from the psycho-pharmaceutical industry to sell powerful money making drugs for life. To remind ourselves as clinicians that mental illness labels are not real, but a cluster of symptoms, that describe a persons perception of reality to enable directed treatment and internal psychiatric discussion with familiar terms that mean something to the treating doctors.
Schizophrenia like many other mental illness labels describe a cluster of symptoms that can explain the mental state of the person presenting to a mental health profession such as a psychiatrist, clinical psychologist and psychiatric nursing. When a potential patient arrives at the hospital for initial consultation some predisposing information arrives with them. These … Read More